Related Experiment Videos
Renal osteodystrophy in rats with reduced renal mass
A Moscovici1, J Bernheim, M M Popovtzer
1Nephrology and Hypertension Service, Hadassah University Hospital, Jerusalem, Israel.
Summary
This study on rats with chronic renal insufficiency shows that reduced kidney mass increases bone resorption but suppresses bone formation. Calcitriol treatment suppressed resorption but did not improve bone formation, leading to adynamic bone disease.
Area of Science:
- Nephrology
- Bone Biology
- Experimental Pathology
Background:
- The rat remnant kidney model is used to study renal failure and bone changes.
- Standardization challenges exist for age and renal failure severity in this model.
- This study aims to refine the evaluation of histomorphometric changes and calcitriol response.
Purpose of the Study:
- To evaluate histomorphometric bone changes in rats with reduced renal mass.
- To assess these changes over an extended follow-up period.
- To define the response to pharmacological doses of calcitriol.
Main Methods:
- Male rats underwent 5/6 nephrectomy to induce renal failure.
- Evaluations occurred at 4 and 8 weeks post-nephrectomy, compared to controls.
- Plasma biochemistry, creatinine clearance, parathyroid hormone (PTH), and tibial bone histomorphometry were analyzed.
Main Results:
- Renal failure induced increased PTH and bone resorption, with suppressed bone formation.
- Long-term follow-up showed even more prominent suppression of bone formation.
- Calcitriol suppressed bone resorption and increased osteoid, but bone formation rate remained low.
Conclusions:
- The rat model mimics human secondary hyperparathyroidism's bone resorption but differs in bone formation.
- Calcitriol treatment in rats and humans with severe secondary hyperparathyroidism can lead to adynamic bone disease.
- This model aids in understanding human renal osteodystrophy, despite species differences.